Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion

Cancer Research

Volumn 60, Issue 6, 2000, Pages 1561-1570

  DiGiovanni, John ^a   Bol, David K ^a,c   Wilker, Erik ^a   Beltrán, Linda ^a   Carbajal, Steve ^a   Moats, Samantha ^a   Ramirez, Angel ^b   Jorcano, José ^b   Kiguchi, Kaoru ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b CIEMAT   (Spain)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASAL CELL; BASAL CELL CARCINOMA; CARCINOGENESIS; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; TRANSGENIC MOUSE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CATTLE; EPIDERMIS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KERATINS; MALE; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS; SKIN; SKIN NEOPLASMS; TETRADECANOYLPHORBOL ACETATE; TRANSGENES;

EID: 0034653704     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Baserga, R. The insulin-like growth factor 1 receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
2. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-1 receptor in cell growth, transformation, and apoptosis. Biochem. Biophys. Acta, 1332: F105-F126, 1997.
3. Jones, J. I., and Clemmons, D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev., 16: 3-34, 1995.
4. Aaronson, S. A. Growth factors and cancer. Science (Washington DC), 254: 1146-1153, 1991.
5. Le Roith, D., Parrizas, M., and Blakesley, V. The insulin-like growth factor-1 receptor and apoptosis. Endocrine, 7: 103-105, 1998.
6. Yee, D., Paik, S., Lebovic, G., Marcus, R., Favoni, R., Cullen, K., Lippman, M., and Rosen, N. Analysis of insulin-like growth factor 1 gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol. Endocrinol., 3: 509-517, 1989.
7. Tricoli, J., Rall, L., Karakousis, C., Herrera, L., Petrelli, N., Bell, G., and Shows, T. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res., 46: 6169-6173, 1986.
8. Minuto, F., Del Monte, P., Barreca, A., Fortini, P., Cariola, G., Catrambone, G., and Giordano, G. Evidence for an increased somatomedin-C/insulin-like growth factor 1 content in primary human lung tumors. Cancer Res., 46: 985-988, 1986.
9. Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., and Pollak, M. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science (Washington DC), 279: 563-566, 1998.
10. Rho, O., Bol. D., You, J., Beltran, L., Rupp, T., and DiGiovanni, J. Altered expression of insulin-like growth factor 1 and its receptor during multistage carcinogenesis in mouse skin. Mol. Carcinog., 17: 62-69, 1996.
11. Kaleko, M., Rutter, W., and Miller, A. Overexpression of the human insulin-like growth factor 1 receptor promotes ligand-dependent neoplastic transformation. Mol. Cell. Biol., 10: 464-473, 1990.
12. Dawson, T. P., Radulescu, A., and Wynford-Thomas, D. Expression of mutant p21ras induces insulin-like growth factor 1 secretion in thyroid epithelial cells. Cancer Res., 55: 915-920, 1995.
13. Vardy, D., Kari, C., Lazarus, G., Jensen, P., Zilberstein, A., Plowman, G., and Rodeck, U. Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/insulin-like growth factor-1. J. Cell. Physiol., 163: 257-265, 1995.
14. Sell, C., Rubini, M., Rubin, R., Liu, J-P., Efstratiadis, A., and Baserga, R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor. Proc. Natl. Acad. Sci. USA, 90: 11217-11221, 1993.
15. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., De Angelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. Effect of a null mutation of the type I IGF receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol., 14: 3604-3612, 1994.
16. Bol. D., Kiguchi, K., Gimenez-Conti, I., Rupp, T., and DiGiovanni, J. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice. Oncogene, 14: 1725-1734, 1997.
17. Rothnagel, J. A., Longley, M. A., Bundman, D., Greenhalgh, D. A., Dominey, A. M., and Roop, D. R. Targeting gene expression to the epidermis of transgenic mice: potential applications to genetic skin disorders. J. Investig. Dermatol., 95: 59S-61S, 1990.
18. Greenhalgh, D. A., Rothnagel, J. A., Quintanilla, M. I., Orengo, C. C., Gagne, T. A., Bundman, D. S., Longley, M. A., and Roop, D. R. Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v-Ha-ras oncogene. Mol. Carcinog., 7: 99-110, 1993.
19. Liu, J-P., Baker, J., Perkins, A., Robertson, E., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor 1 and type 1 IGF receptor. Cell, 75: 59-72, 1993.
20. Mathews, L. S., Hammer, R. E., Behringer, R. R., D'Ercole, J., Bell, G. I., Brinster, R. L., and Palmiter, R. D. Growth enhancement of transgenic mice expressing insulin-like growth factor I. Endocrinology, 123: 2827-2833, 1988.
21. Regler, C. E., Yang, D., Rossetti, L., Donohoe, J., Alt, E., Chang, C. J., Rosenfeld, R., Neely, K., and Hintz, R. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor II transgenic mice. J. Biol. Chem., 269: 13779-13784, 1994.
22. Ward, A., Bates, P., Fisher, R., Richardson, L., and Graham, C. F. Disproportionate growth in mice with Igf-2 transgenes. Proc. Natl. Acad. Sci. USA, 91: 10365-10369, 1994.
23. Ramirez, A., Bravo, A., Jorcano, J. L., and Vidal, M. Sequences 5′ of the bovine keratin 5 gene direct tissue-and cell type-specific expression of a LacZ gene in the adult and during development. Differentiation, 58: 53-64, 1994.
24. Casatorres, J., Navarro, J., Blessing, M., and Jorcano, J. Analysis of the control of expression and tissue specificity of the keratin 5 gene, characteristic of basal keratinocytes. J. Biol. Chem., 32: 20489-20496, 1994.
25. Bol, D., Kiguchi, K., Beltrán, L., Rupp, T., Moats, S., Gimenez-Conti, I., Jorcano, J., and DiGiovanni, J. Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the Neu oncogene under the control of the bovine keratin 5 promoter. Mol. Carcinog., 21: 2-12, 1998.
26. Jansen, M., van Schaik, F. M. A., Ricker, A. T., Bullock, B., Woods, D. E., Gabbay, K. H., Nussbaum, A. L., Sussenback, J. S., and Van den Brande, J. L. Sequence of cDNA encoding human insulin-like growth factor 1 precursor. Nature (Lond.), 306: 609-611, 1983.
27. 3H]thymidine administered by injection or osmotic pump. Carcinogenesis (Lond.), 4: 281-284, 1990.
28. Naito, M., Naito, Y., and DiGiovanni, J. Comparison of the histological changes in the skin of DBA/2 and C57BL/6 mice following exposure to various promoting agents. Carcinogenesis (Lond.), 8: 1807-1815, 1987.
29. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
30. Auger, K. R., Serunian, L. A., Soltoff, S. P., Libby, P., and Cantley, L. C. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell, 57: 167-175, 1989.
31. Vassar, R., Hutton, M., and Fuchs, E. Transgenic overexpression of transforming growth factor bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol. Cell. Biol., 12: 4643-4653, 1992.
32. Wang, X-J., Greenhalgh, D., Eckhardt, J., Rothnagel, J., and Roop, D. Epidermal expression of transforming growth factor α in transgenic mice: induction of spontaneous and 12-0-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression. Mol. Carcinog., 10: 15-22, 1994.
33. Pelling, J. C., Neades, R., and Strawhecker, J. Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone contain a point mutation in the 61st codon of the Ha-ras oncogene. Carcinogenesis (Lond.), 9: 665-667, 1988.
34. Loktionov, A., Popovich, I., Zabezhinski, M., Martel, N., Yamasaki, H., and Tomatis, L. Transplacental and transgeneration carcinogenic effect of 7,12-dimethylbenz[a]anthracene: relationship with ras oncogene activation. Carcinogenesis (Lond.), 13: 19-24, 1992.
35. Loktionov, A., Hollstein, M., Martel, N., Galendo, D., Cabral, J., Tomatis, L., and Yamasaki, H. Tissue-specific activating mutations of Ha-and Ki-ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposures to DMBA. Mol. Carcinog., 3: 134-140, 1990.
36. DiGiovanni, J., Beltran, L., Rupp, A., Harvey, R. G., and Gill, R. D. Further analysis of c-Ha-ras mutations in papillomas initiated by several polycyclic aromatic hydrocarbons or from uninitiated, promoter treated skin of SENCAR mice. Mol. Carcinog., 8: 272-279, 1993.
37. DiGiovanni, J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther., 48: 63-128, 1992.
38. White, M., and Kahn, C. R. The insulin signaling system. J. Biol. Chem., 269: 1-4, 1994.
39. Ziegler, A., Jonason, A. S., Lefell, D. J., Simon, J. A., Sharma, H. W., Kimmelmann, J., Remington, L., Jacks, T., and Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature (Lond.), 372: 773-776, 1994.
40. Pena, J., Rudin, C., and Thompson, C. A BCL-XL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res., 58: 2111-2116, 1998.
41. Rodriguez-Villanueva, J., Greenhalgh, D., Wang, X-J., Bundman, D., Cho, S., Delehedde, M., Roop, D., and McDonnell, T. J. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation. Oncogene, 16: 853-863, 1998.